Vivos Therapeutics Study Confirms OSA Correlation with Facial Morphology
Vivos Therapeutics announced that an a recent published study supports Vivos' long maintained belief that dental and facial morphology characterized by narrow palatal dental arches, high peaked palates, and recessed lower jaws were directly correlated to the prevalence and severity of obstructive sleep apnea, or OSA, in adults and children. Vivos CARE devices have been cleared by the FDA for adult patients diagnosed with mild, moderate and severe OSA and moderate-to-severe OSA in children ages 6 to 17. Many Vivos patients finish treatment in less than 12 months with little or no remaining OSA symptoms. The OSA group exhibited significantly narrower transverse intermolar distance and higher palatal height compared to the control group. Linear regression analysis demonstrated a strong association between these two key craniofacial parameters and OSA severity, as measured by the industry standard measure AHI. These results held true across all demographics.
